Richard Scheller
| Richard H. Scheller | |
|---|---|
| Born |
October 30, 1953 Milwaukee, Wisconsin |
| Nationality | American |
| Fields | Neuroscience |
| Institutions | Genentech, University of California San Francisco |
| Alma mater | University of Wisconsin–Madison, California Institute of Technology, Columbia University |
| Doctoral advisor | Eric H. Davidson |
| Other academic advisors | Eric Kandel, Richard Axel |
| Known for | Head of gRED |
| Notable awards |
NAS Award in Molecular Biology (1997) Kavli Prize (2010) Albert Lasker Award for Basic Medical Research (2013) |
Richard H. Scheller (born 30 October 1953) is the Chief Science Officer & Head of Therapeutics at 23andMe and the former Executive Vice President of Research and Early Development at Genentech. He was a Professor at Stanford University from 1982 to 2001 before joining Genentech. He has been awarded the Alan T. Waterman Award in 1989, the W. Alden Spencer Award in 1993 and the NAS Award in Molecular Biology in 1997, won the 2010 Kavli Prize in Neuroscience with Thomas C. Südhof and James E. Rothman, and won the 2013 Albert Lasker Award for Basic Medical Research with Thomas Sudhof. He was also given the Life Sciences Distinguished Alumni Award from University of Wisconsin–Madison. He is a Fellow of the American Academy of Arts and Sciences and a Member of the National Academy of Sciences.
He earned his B.S. in biochemistry from the University of Wisconsin–Madison and his Ph.D. in chemistry from the California Institute of Technology under the guidance of Eric H. Davidson. While a graduate student, he worked with Keiichi Itakura and Arthur Riggs to help synthesize Somatostatin for Herb Boyer at Genentech. After finishing his graduate studies, he did a brief postdoc with Davidson and later with Eric Kandel and Richard Axel at Columbia University. While at Columbia, he extended his previous work with recombinant DNA to identify the egg-laying hormone (ELH) gene family of neuropeptides.
...
Wikipedia